|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues from Services | |||||
| Sale of Products | |||||
| Sales of Products | |||||
| Total revenues | |||||
| Cost of revenues | |||||
| Cost of Services | |||||
| Cost of Products Sold | |||||
| Total cost of revenues | |||||
| Gross profit | |||||
| Research and development expenses | |||||
| Sales and marketing expenses | |||||
| General and administrative expenses | |||||
| Other (expense)/income, net | |||||
| Income from operations | |||||
| Interest income | |||||
| Interest expenses | |||||
| Income before income tax | |||||
| Income tax expenses | |||||
| Net loss | |||||
| Share of profit/(loss) in equity method investments, net of tax | |||||
| Net income | |||||
| Foreign currency translation adjustment | |||||
| Total comprehensive income | |||||
| Net earnings per share attributable to ordinary shareholders of the Company | |||||
| Basic (in Dollars per share) | |||||
| Diluted (in Dollars per share) | |||||
| Weighted average number of ordinary shares used in computing net earnings per share | |||||
| Basic (in Shares) | |||||
| Diluted (in Shares) | |||||
| Net income attributable to ordinary shareholders of the Company | |||||
Loading...